CRISPR/Cas9-based genome editing technology
A robust CRISPR/Cas9 vector system for multiplex targeting of
genomic sites in monocot and dicot plants
ÑÇÈÈ´øÅ©ÒµÉúÎï×ÊÔ´±£»¤ÓëÀûÓùú¼ÒÖØµãʵÑéÊÒ
»ªÄÏũҵ´óѧÉúÃü¿ÆÑ§Ñ§Ôº
ÁõÒ«¹â¿ÎÌâ×é
(ygliu@scau.edu.cn)
1. pYLCRISPR/Cas9¶à°ÐµãÔØÌå½éÉÜ
CRISPR/Cas9ÊÇнü·¢Õ¹µÄ»ùÒò×é±à¼¼¼Êõ£¨Í¼1£©¡£CRISPR/Cas9Çиî°ÐÐòÁнöÐèÒªsingle-guide RNA (sgRNA)ÒÔ¼°ÓÉsgRNAÒýµ¼µÄCas9µ°°×£¬±ÈпָºËËáø£¨ZFNs£©£¬TALENs¸ü¼Ó¼ò±ã£¬¸ßЧ£¬Òò¶ø³ÉΪ»ùÒò×é±à¼¹¤¾ßµÄÊ×Ñ¡¡£
ÎÒÃÇÀûÓÃCRISPR/Cas9¼¼Êõ¿É·½±ãµØ½øÐжàÖØ°ÐÏòµÄÌØÕ÷£¬¹¹½¨ÁËÒ»Ì×ÓÃÓÚµ¥×ÓÒ¶ºÍË«×ÓÒ¶Ö²ÎïµÄ¶à°ÐµãCRISPR/Cas9»ùÒò´ò°ÐÔØÌåϵͳ¡£
±¾Ì×ÔØÌ彫Cas9µ°°×±í´ïºÐÕûºÏµ½Ë«ÔªÔØÌåÉÏ£¬ÓÃÓÚ×°ÔØ¶à¸ösgRNA±í´ïºÐµÄ¶à¿Ë¡λµãBsa IλÓÚ¿¿½üË«ÔªÔØÌåRBλÖá£sgRNA±í´ïºÐÔª¼þÉèÔÚÖмäÖÊÁ£ÔØÌåÉÏ£¬ÀûÓÃøÇÐÁ¬½ÓºÍPCR·½·¨Æ´×°ºÃ£¬ÔÙÀûÓÃGolden Gate»òGibson Assembly¿Ë¡·½·¨×é×°µ½Ë«ÔªÔØÌåÉÏ¡£
Cas9 nucleaseRuvC-like domainHNH domainTarget Site PAMNGGNNNNNNNNNNNN-3¡¯genome NCCNNNNNNNNNNNN-5¡¯sequenceAA5¡¯ NNNNNNNNNNNN3¡¯ NNNNNNNNNNNNGNNNNNNNNNNNNNNNNNNNCleavage siteNNNNNNNNNNNNNNNNNNNN5¡¯-G/ANNNNNNNNNNNNNNNNNNNNGUUUUAGAGCUAGAACUAUUGCCUGAUCGGAAUAAAAUUCGAUAGAAFigure 1. A working model of the CRISPR/Cas9 system. The Cas9-sgRNA complex locates to the target site to cleave the DNA to produce double strand break (DSB).
1
CUUGAAAAAGUGGCACCGAUUUUU-3¡¯GCGUGGCU
2£®CRISPR/Cas9ÔØÌåÓësgRNAÔØÌåͼÆ×
2.1CRISPR/Cas9Ë«ÔªÔØÌå
±¾Ì×ÔØÌåϵͳµÄË«ÔªÔØÌå¹Ç¼ÜΪpCAMBIA-1300 (ACCESSION: AF234296)£¬Cas9pΪ±¾ÊµÑéÊÒÉè¼ÆºÏ³ÉµÄÖ²ÎïÓÅ»¯ÃÜÂë×Ó»ùÒò£¬ËüÄ£ÄâÁ˺̱¾¿ÆÖ²Îï»ùÒò¾ßÓÐ5¡¯¶ËGCº¬Á¿½Ï¸ßµÄÌØÕ÷ (Figure 2)¡£
ÕâЩÖÊÁ£ÔÚE. coli TOP10F¡¯(LacIq) ¾úÖê·±Ö³£¬¸Ã¾úÖêLacIq»ùÒòÐͲúÉúµÄ×è°µ°°×¿ÉÒÖÖÆccdB´ó³¦¸Ë¾úÖÂËÀ»ùÒòµÄ±í´ï¡£
pYLCRISPR/Cas9Pubi-H, -BÔØÌåÖеÄCas9pÓÃpUbiÇý¶¯£¬ÓÅÑ¡ÓÃÓÚµ¥×ÓÒ¶Ö²ÎïµÄ»ùÒò´ò°Ð£»¶ÔÓÚË«×ÓÒ¶Ö²ÎĿǰÓÅÏÈʹÓÃpYLCRISPR/Cas9P35S-H, -N,-B¡£ÎÒÃÇÓÃpYLCRISPR/Cas9Pubi-HÔÚÄâÄϽæÒ²´ò°Ð³É¹¦£¬µ«ÓëpYLCRISPR/Cas9P35S-H¶ÔÄâÄϽæµÄ´ò°ÐЧÂʱȽÏÕýÔÚ²âÊÔÖС£
ÎÒÃǶÔpYLCRISPR/Cas9ÔØÌå²ÉÓÃÁËеÄÃüÃû£¬Óë¾ÉµÄÃüÃû¶ÔÓ¦¹ØÏµ¼û±í1¡£
Figure 2. A CRISPR/Cas9 system for monocot and dicot plants.
pYLCRISPR/Cas9Pubi-H, -B (above); pYLCRISPR/Cas9P35S-H, -N,-B (below); HPT (-H), Bar (-B), and NPT II (-N) encode hygromycin B phosphotransferase, PPT acetyltransferase and neomycin phosphotransferase II, respectively. NLS, nuclear localization sequence. The key sequences including restriction sites for cloning and analysis of sgRNA expression cassettes are given. Two Bsa I-cutting sties [Bsa I (B-L) and Bsa I (B-R)] for cloning the sgRNA expression cassettes are
separated by a shorten form of the ccdB negative selection gene.
2
±íÒ» pYLCRISPR/Cas9ÔØÌåоÉÃüÃû¶ÔÓ¦¹ØÏµ ÐÂÃüÃû
pYLCRISPR/Cas9Pubi-H
ÔÃüÃû
pYLCRISPR/Cas9-MH, pYLCRISPR/Cas9-MTmono
pYLCRISPR/Cas9Pubi-B pYLCRISPR/Cas9P35S-H pYLCRISPR/Cas9P35S-B pYLCRISPR/Cas9P35S-N
pYLCRISPR/Cas9-MB pYLCRISPR/Cas9-DH pYLCRISPR/Cas9-DB pYLCRISPR/Cas9-DN
µ¥×ÓÒ¶/Ë«×ÓÒ¶ Ë«×ÓÒ¶ Ë«×ÓÒ¶ Ë«×ÓÒ¶
²Ý¸ÊÁ× ³±Ã¹ËØ ²Ý¸ÊÁ× ¿¨ÄÇÃ¹ËØ
ÊÊÓÃÖ²ÎïÖÖ µ¥×ÓÒ¶/Ë«×ÓÒ¶
Ö²ÎÐÔ ³±Ã¹ËØ
2.2 CRISPR/sgRNA vectors
sgRNAÐòÁÐÈ«³¤96 nt£¬·ÖΪÁ½²¿·Ö£¬5¡¯¾ö¶¨°ÐÐòÁеÄ20¼î»ù (seed sequence)ºÍ3¡¯ÇøÓòΪ±£ÊصĽṹÐòÁС£Òò´Ë¹¹½¨Õë¶ÔÌØ¶¨°ÐλµãµÄsgRNA£¬Ö»ÐèÒª¿Ë¡¾ö¶¨°ÐÐòÁеÄ5¡¯¶Ë20 nt (seed sequence)¡£ sgRNAÓÃsmall nuclear (sn) RNA U6/U3Æô¶¯×ÓÇý¶¯£¬ÒÔ±£Ö¤×ªÂ¼³öµÄsgRNAÍ£ÁôÔÚϸ°ûºËÖÐÓëCas9½áºÏ¡£
±¾·½°¸ÓÃPCRÀ©ÔöµÄ·½·¨¹¹½¨°üº¬°ÐÐòÁеÄsgRNA±í´ïºÐ£¬²¢ÔÚÀ©ÔöÒýÎï5¡¯¶ËÒýÈë˳´ÎÅÅÁеÄλÖÃÌØÒìBsa I øÇÐλµã£¬ÓÃÓÚGolden Gate¿Ë¡¡£»òÔÚÀ©ÔöÒýÎï5¡¯¶Ë¼ÓÈ뻥²¹ÐòÁÐÓÃÓÚGibson Assembly Á¬½Ó¿Ë¡¡£
ΪÁËÌá¸ß¹¹½¨ºÃµÄ¶à°ÐµãÔØÌåµÄÎȶ¨ÐÔ£¬±ÜÃâÔÚÅ©¸Ë¾ú»òÕßÖ²Îï»ùÒò×éÖÐsgRNA±í´ïºÐÖ®¼ä·¢ÉúÍ¬Ô´ÖØ×飬´ÓË®µ¾¿Ë¡ÁË4¸ö²»Í¬snRNAÆô¶¯×Ó(OsU3,OsU6a£¬OsU6b£¬OsU6c)£¬ÓÃÓÚµ¥×ÓÒ¶Ö²Î´ÓÄâÄϽæÖпË¡ÁË4¸ö²»Í¬snRNAÆô¶¯×Ó£¨AtU3b£¬AtU3d£¬AtU6-1£¬AtU6-29£©£¬ÓÃÓÚË«×ÓÒ¶Ö²Îï¡£
3
Figure 3£®(A) Overall structure of eight basic sgRNA intermediate vectors. (B) The two Bsa I cutting
sequences are given in twelve sgRNA vectors (in a linear form), including other four vectors (pYLsgRNA-OsU3/LacZ, pYLsgRNA-OsU6a/LacZ, pYLsgRNA-AtU3b/LacZ, and pYLsgRNA-AtU3d/LacZ) that have an additional LacZ gene (198 bp) as a cloning selection marker. The U3 and U6 promoters from rice (Os) and Arabidopsis (At) and the sgRNA sequence are separated by the vector backbone, to avoid amplification of the uncut plasmids by PCR with short extension time during the construction of sgRNA expression cassettes. Cutting (small arrows) with Bsa I produces different non-palindromic sticky ends to the promoters and an end to the sgRNA sequence. (C) A representative regular target and an irregular target, their target adaptors for the OsU6a promoter, and the transcribed 5¡¯ sequences are shown. A ligated target-sgRNA expression cassette is amplified by nested PCR using primers U-F/gR-R and Pps/Pgs. Pps and Pgs are position-specific primers with Bsa I sites for the Golden Gate ligation (Table S1), or with overlapping ends for Gibson Assembly (Table S3).
3.°ÐλµãÑ¡ÔñºÍ½ÓÍ·Éè¼Æ
3.1 °ÐλµãÑ¡Ôñ
½¨Òé¶Ô1¸öÄ¿µÄ»ùÒòÉè¼Æ2¸ö°Ðµã(ÓÈÆäÖ»ÓÐÒ»¸ö°Ð»ùÒò)£¬ÒÔ½µµÍij°Ðµã´ò°Ð²»³É¹¦µÄ·çÏÕ¡£¿ÉÔÚORF 5¡¯ÇøºÍ¹¦ÄܽṹÓò¸÷Éè¼Æ1¸ö°Ðµã£¬Ê¹Ö®ÈκÎ1¸ö°ÐµãµÄÍ»±ä¶¼¿ÉÒÔ²úÉú¹¦ÄÜȱʧ£¬»ò2¸ö°ÐµãÖ®¼äµÄÐòÁб»Çóý¡£Éè¼Æ°ÐµãµÄÔÔò£º
(1) Ä¿µÄ»ùÒòµÄÕýÁ´ºÍ¸ºÁ´°ÐµãµÄ´ò°ÐЧÂÊ´óÖÂÏàͬ£¬¶¼¿ÉÒÔÉè¼Æ°Ðµã£» (2) Regular targets & irregular targets (¼ûÒÔÏÂ˵Ã÷)ÓÐͬµÈ´ò°ÐЧÂÊ£»
(3) °ÐµãµÄGC%¾¡Á¿²»ÒªµÍÓÚ40%£¬°ÐµãÐòÁÐGC%Æ«¸ß(50-75%)ÓнϸߵĴò°ÐЧÂÊ¡£°ÐµãÄÚ(°´
5-N20NGG-3·½Ïò)²»ÒªÓÐÁ¬Ðø4¸öÒÔÉϵÄT£¬ÒÔ·ÀRNA Pol III½«Æä×÷Ϊת¼ÖÕÖ¹Ðźţ»
(4) ËäÈ»·ÇÌØÒì´ò°Ð£¨ÍѰУ©¶ÔÖ²Îï»ùÒò´ò°Ð²»ÊǺÜÖØÒªµÄÎÊÌ⣬µ«Ó¦½øÐаеãÌØÒìÐÔ·ÖÎö£ºÓðеã+NGG
£¨Ç°ºó¸÷¼Ó¼¸Ê®¼î»ù£©Óë»ùÒò×é×öblast (Ñ¡Somewhat similar sequences£©£¬±ÜÃâʹÓÃÓëͬԴÐòÁвîÒìÉÙÓÚ5¸ö¼î»ùµÄ°Ðµã(ÔÚÇе㸽½üºÍPAM¿ÉÓÐ2¸ö¼î»ù²îÒì¾Í¾ßÓÐÌØÒìÐÔ)¡£¿ÉÒÔʹÓÃÔÚÏßÈí¼þCRISPR-P (http://cbi.hzau.edu.cn/crispr/)×öÕâ¸ö·ÖÎö£¬µ«¿ÉʹÓõİеãÐòÁв»Ò»¶¨ÎªRegular targets (AN19NGG»òGN19NGG)£¬¼ûÒÔϹØÓÚRegular target & irregular target˵Ã÷¡£
(5) ´òËãÓÃÒ»¸ö°ÐÐòÁÐÇóý2¸ö»òÒÔÉϵÄͬԴ»ùÒòʱ£¬Ñ¡ÔñͬԴ»ùÒòÖмî»ùÍêÈ«ÏàͬµÄÇøÓòΪ°Ðλµã¡£
(6) °Ñ°ÐµãÐòÁÐÁ¬½Óµ½sgRNAÐòÁеÄ5¡¯¶Ë[(20 bp target)GTTTTAGAGCTAGAAATAGCAAGTTAAAATAA
GGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT],ÀûÓÃÔÚÏßÈí¼þ
(http://mfold.rna.albany.edu/?q=mfold/RNA-Folding-Form2.3)×ö¶þ¼¶½á¹¹·ÖÎö¡£°ÐÐòÁÐÓësgRNAÐòÁвúÉúÁ¬ÐøÅä¶Ô7 bp£¨×¢Ò⣺RNA¿ÉÒÔ²úÉúU-GÅä¶Ô£©ÒÔÉÏ»áÒÖÖÆÆäÓëȾɫÌåDNA°ÐÐòÁнáºÏ°Ðµã£¬Òò´ËÒª±ÜÃâʹÓÃÁ¬ÐøÅä¶Ô7 bpÒÔÉϵİÐÐòÁС£
3.2°Ðµã½ÓÍ·Éè¼Æ
U6/U3»ùÒòÓÉIIIÐÍRNA¾ÛºÏøת¼£¬×ªÂ¼ÆðʼµãÊÇÈ·¶¨µÄ¼î»ùλÖá£ÀýÈ磬U6ΪG¼î»ù£¬U3ΪA¼î»ù¡£Òò´Ë£¬ÓÉU6/U3Æô¶¯×ÓÇý¶¯µÄsgRNAÊ×¼î»ùÒ»¶¨ÊÇG»òÕßA¡£µ«ÊÇÉè¼ÆµÄ°ÐÐòÁеÄÊ×¼î»ù²»Ò»¶¨¸ÕºÃÊÇG»òÕßA£¬Òò´ËÉè¼Æ½ÓÍ·ÒýÎïʱÐè·ÖÁ½ÖÖÇé¿ö¿¼ÂÇ£º £¨1£©Èç¹ûÄ¿±êÇøNGG(PAM)ÉÏÓεÚ20¼î»ùÊÇA£¨ÓÃU3Æô¶¯×Ó£©»òG(ÓÃU6a~cÆô¶¯×Ó£©£¬×÷Ϊ³£¹æ°Ðµã(regular target)£¬½«A/GÏÂÓÎ19¼î»ù¿É°´ÏÂͼËùʾºÏ³É½ÓÍ·¡£
4